The Power of Pricing Transparency in Early Communication Even if your product or test has not yet been approved by the FDA, transparency in pricing strategies stands out as a key differentiator when you ask a formulary committee or review board for a review. The Format Executive Committee of the AMCP strongly advocates for pharmaceuticalContinue reading “Pricing Transparency in Dossiers Increases Committee Trust”
Medical Writing & Research